W.K. Kellogg Foundation Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-251,225
Closed -$28.1M 6
2020
Q2
$28.1M Buy
+251,225
New +$24.7M 0.68% 3

Other funds holding XBI

W.K. Kellogg Foundation Trust's XBI Position: Q3 2020 in Review

W.K. Kellogg Foundation Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2020, closing a stake of 251,225 shares — an estimated $28.1M sold.

W.K. Kellogg Foundation Trust first reported a position in XBI in Q2 2020 and held it in 1 quarter. The position peaked at $28.1M in Q2 2020. 554 funds tracked by Wall St. Rank hold XBI as of Q3 2020.

  • W.K. Kellogg Foundation Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2020 after selling out during the quarter.
  • W.K. Kellogg Foundation Trust sold 251,225 State Street SPDR S&P Biotech ETF shares in Q3 2020, an estimated $28.1M.
  • W.K. Kellogg Foundation Trust first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 1 quarter.
  • W.K. Kellogg Foundation Trust's State Street SPDR S&P Biotech ETF position peaked at $28.1M in Q2 2020.
  • 554 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2020.

Based on W.K. Kellogg Foundation Trust's 13F filing for Q3 2020, filed 12 Nov 2020.